Activity
2K followers
-
Ben Magnano reposted thisBen Magnano reposted thisYep....I can relate. Thank you, Todd Lieweke. "Troubling him is how majority Democrats in Olympia are managing the state’s finances and what he described as a souring mood among business leaders, who are questioning if Washington is where they want to be. 'In my time, I have not felt as much fear in the business community as I feel today,' Leiweke said. 'This isn’t about the millionaire tax. This is about an insatiable appetite of spending beyond your means,' Leiweke added. 'I’ve been a lifelong Democrat. I’m telling the Democratic Party: ‘It is time to wake up.’ We can be a blue state that has a fiscal plan. Today, we’re a blue state without a fiscal plan.'" https://lnkd.in/g46qyVq9Kraken CEO warns that Washington state business leaders are eyeing exitsKraken CEO warns that Washington state business leaders are eyeing exits
-
Ben Magnano liked thisBen Magnano liked thisFrazier Healthcare Partners is proud to announce Tom Rodgers will be joining the firm as a Senior Partner in October 2026. In this role, Tom will partner with Frazier’s Buyout deal teams, providing strategic counsel on investment evaluation, portfolio value creation, and sector-level insights informed by more than 35 years of experience in healthcare strategy, corporate development, and investing. “Frazier’s singular focus on healthcare and its reputation for building market-leading companies in partnership with great management teams are what drew me to this opportunity,” said Tom Rodgers. “I look forward to working alongside the team, many of whom I have known and respected for years, to identify and support the next generation of companies transforming healthcare delivery.” Read more here: https://lnkd.in/gPg3keuy
-
Ben Magnano liked thisBen Magnano liked thisFrazier Healthcare Partners is pleased to announce the addition of Priti Shah to its Center of Excellence team, as Partner, Product Excellence. Priti is a healthcare technology executive with over 20 years of experience spanning product, technology, and commercial leadership. Most recently, she served as Chief Product & Technology Officer of Iodine Software, a provider of AI-powered clinical intelligence solutions, where she owned the full product platform, including engineering, data science, design, infrastructure, and strategic marketing. “Every healthcare company I’ve worked with faces a version of the same challenge: how to evolve from a point solution into a platform that compounds value,” said Ms. Shah. “Frazier’s portfolio sits at the center of that transition, spanning provider technology, clinical intelligence, and healthcare services. I’m excited to work alongside these management teams at the moments when product and strategic decisions can have the greatest impact on long-term enterprise value.” Read more about Frazier’s Center of Excellence, and Priti’s hire, here: https://lnkd.in/gRATjRrA
-
Ben Magnano liked thisBen Magnano liked thisFrazier Healthcare Partners is pleased to announce the hire of Wesley Wheeler as an Executive in Residence on the Buyout team. In this role, Wes will support Frazier’s investment professionals with diligence efforts and sector insights in life science logistics and infrastructure, while also advising portfolio leadership teams on operational performance, strategic growth initiatives, and value creation. “Frazier’s reputation for partnering with management teams to build market-leading healthcare businesses is well earned, and I have seen firsthand the caliber of companies they support,” said Wes Wheeler. “I look forward to working alongside the team to identify compelling opportunities and help drive operational and financial performance across the portfolio.” Read more about Wes Wheeler here: https://lnkd.in/e_FjrgZy
-
Ben Magnano liked thisBen Magnano liked thisThis August, Frazier Healthcare Partners celebrates its 35th anniversary. When our founder, Alan Frazier, established the firm in 1991, he had a clear vision: "We will invest in innovative companies that are improving the quality, accessibility, and/or affordability of healthcare." This was a novel approach to private equity. Alan was the first to believe that healthcare was large enough and complex enough to justify the full attention of a dedicated private equity firm. He was a pioneer, and Frazier Healthcare Partners became one of the first firms to invest exclusively in the healthcare sector. Alan also had a clear philosophy for how the first firm would operate, grounded in a single principle: "We will leave everyone we touch better off because of our work together." That commitment extends to our portfolio company employees, the clients and patients they serve, the communities in which they operate, and the investors who entrust us to deliver differentiated returns. While the healthcare industry has continued to evolve, the principles that guide our firm have not. They continue to shape how we invest, how we build partnerships, and how we approach our work every day. As we mark this milestone, we're grateful to everyone who has been part of our story. To our employees, portfolio company leaders, investors, advisors, EIRs, and partners: thank you for your trust, collaboration, and commitment over the past 35 years. We're proud of what we've built together and energized by what lies ahead. Here's to the next chapter and to continuing to invest in the people, companies, and innovations shaping the future of healthcare.
-
Ben Magnano liked thisBen Magnano liked thisAfter a deeply fulfilling chapter, and with mixed emotions I have decided to retire from McKesson—a company whose mission and impact I will always admire. To my McKesson colleagues, thank you for your unwavering commitment to improving patients’ healthcare experiences and outcomes; your work truly matters. To my strategy teammates, I’m grateful for your thoughtful dedication to shaping a strong future for an organization with a long history of helping our healthcare system run. As you continue that work, remember: “be a compass, not a weathervane”. While I’m closing this chapter, there’s another one ahead, and I’m excited for what comes next
-
Ben Magnano liked thisBen Magnano liked thisBioMatrix Infusion Pharmacy is excited to share that we have expanded our Western U.S. presence with the acquisition of Total Infusion Care, further strengthening access to high-quality infusion services for patients and providers across the region. Read more: https://lnkd.in/gE4a_PppBioMatrix Infusion Pharmacy Expands Western U.S. Footprint with Acquisition of Total Infusion Care — BioMatrix Infusion PharmacyBioMatrix Infusion Pharmacy Expands Western U.S. Footprint with Acquisition of Total Infusion Care — BioMatrix Infusion Pharmacy
-
Ben Magnano liked thisGreat stuff happening here at Notre Dame, Go IRISH!Ben Magnano liked thisOn October 3, we hosted the 2025 Brumm Patient Advocacy Summit, with over 200 attendees, including students, patients and caregivers, faculty and staff, and partners from industry, healthcare, and patient advocacy groups. This year, the summit showcased the unique perspectives and strengths of students with disabilities, the patient-focused drug development process, a workshop with National Organization for Rare Disorders, and a keynote speech from Bryce Walker, who shared his experience as a Notre Dame graduate and young adult living with Sarcoidosis. After the Summit, we celebrated in community at the first-ever Rare Rally. If you were not able to attend this year’s summit, we encourage you to view the recording, which can be found here: https://lnkd.in/gtPvcpaJ We want to extend a heartfelt thank you to Josh Brumm and his family for their continued support and passion for the Summit, all of the speakers and panelists, especially our Notre Dame (Annie Hamilton, Nyla White) and LEVEL Villanova University (Tynan Davidson and Gabriel Donovan) students, Emily Voorde, Christopher Cassidy, Annie Kennedy from EveryLife Foundation for Rare Diseases, Tim Franson, M.D. from Faegre Drinker Consulting, Sean Kassen from Ara Parseghian Medical Research Fund, Carolyn Sheridan, MPH and Jake Saltonstall, MPA from National Organization for Rare Disorders, and our partners from RMHC Michiana, Uplifting Athletes, A Rosie Place for Children, Catalyst Pharmaceuticals, Inc., Crescent Biopharma, and PTC Therapeutics, Inc. for playing a role in the day! We are so grateful for the many ways you all contribute to advancing rare disease awareness and advocacy. We invite you to stay connected as we look ahead to Rare Disease Day 2026! Our campus and community will again come together to honor those impacted by rare diseases as we #LightUpForRare. Details will be shared early next semester, but you can get a preview of prior activities here: https://lnkd.in/gqtGjVqK
-
Ben Magnano liked thisBen Magnano liked thisBig news! We have entered into an agreement to acquire Kyruus Health. Together, we’re building a connected platform that simplifies every step of the healthcare journey, from the first search to the final statement. By combining RevSpring’s strengths in patient engagement and payments with Kyruus’ expertise in provider data and scheduling, we’ll deliver a more seamless, personalized experience for patients/members, providers, and payers alike. We’re thrilled to welcome Kyruus to the RevSpring team and take this important step toward transforming the healthcare experience! Read the full release here: https://bit.ly/4mrx5SD #HealthcareInnovation #PatientExperience #DigitalHealth #Growth
Experience & Education
Other similar profiles
Explore more posts
-
2CarrotsVC | Healthcare
Ferry Health has raised $9M in Seed funding from Andreessen Horowitz, Index Ventures, Avid Ventures, Layout Ventures, SV Angel, BoxGroup and Asymmetric, alongside angel investors including Jay Desai and the founders of Grow Therapy (Manoj Kanagaraj, MD), Hex and Chapter. The company announced the financing as it emerged from stealth. Founded in 2024 by Mehul Mehta, Keyur Mehta and Andrew Buie, Ferry Health is led by CEO Mehul Mehta and develops an AI-powered healthcare personal assistant that finds in-network providers, verifies availability and coverage, makes calls and books appointments on patients’ behalf. Through partnerships with health systems, insurers and care navigation platforms, Ferry is available to 1M+ patients across all 50 states, with access expected to grow more than fivefold by year-end. Ferry plans to expand beyond appointment scheduling into more of the patient journey. Early customers are already using the platform to coordinate imaging and home health, while longer-term opportunities include transportation coordination and prior authorization visibility. Deal summary Stage: Seed Investment: $9M Number of Investors: 7 institutional investors + angels Date: September 16, 2026 #StartupFunding #Fundraising #HealthTech #DigitalHealth #HealthcareAI #AI #PatientNavigation #CareCoordination #Seed
-
Eran Lerer
The business models that built digital health over the last decade won't look the same in the AI era. We’re moving from paying for access to software to paying for measurable outcomes powered by software. That shift could fundamentally change how digital health companies build, sell, and create value. I shared a few thoughts on this transition in my latest interview with LSI. 🎥 Watch the full discussion: https://lnkd.in/dfAsVCww Thank you to The Mullings Group, Ido Hadari and Caty Pearl for driving this important conversation. #DigitalHealth #AIinHealthcare #HealthTech #LSI #HealthTechVC Ran Goshen, Ofir Hazut, Saar liraz
1 Comment -
Roseanne Wincek
When we first backed Epsilon Health, the company had two employees. The medical imaging industry has been hearing grand AI promises for decades. When we spoke to radiologists and imaging center operators, many of them literally used the term "snake oil." Expectations are low and the bar for implementation is extremely high. Rustin came in with a point of view we had not heard from anyone else. Epsilon sells a finished product to imaging centers that are desperate for capacity, rather than another co-pilot working its way through a health system. Epsilon is a canonical example of what we look for in an AI-native service business: a supply-constrained industry, a regulated workflow, and a job that has to get done. Rustin understands this market deeply, and he built something customers are clamoring to buy. Epsilon is now on track to review 1% of all daily U.S. X-rays in 2026. Congratulations to Rustin Rassoli, Roi Bittane MD, Arjun Karpur and the entire incredible Epsilon Health team.
1 Comment -
Ariel Jalali
Morgan asks the $1TN question: As a healthcare CEO, can you trust OpenAI or Anthropic as your AI one-stop-shop? On the ground implementing AI at healthcare enterprises, the answer is nuanced. It's a trade-off between 2 options: 1. Self-hosted ("Control"): Data security, vendor flexibility, more customizable, more workflow control, but higher maintenance costs. 2. SaaS/API ("Convenience"): SOTA models, built-in best practices, potentially higher availability via SLA, but less workflow control and lower maintenance costs. A hybrid option is emerging: managed AI/automation where you control infrastructure, data, and integration with help from a managed intelligence provider, while the model vendor handles upgrades. AI model companies would be wise to lean into this option. Ultimately it comes down to data security and workflow control. ERP and SaaS cycles taught us that "out of the box best-practice" workflows don't work at enterprise scale without massive customization. AI that learns may ease some of this, but not all. We'll need headless automation that decouples AI models from workflow. (Disclaimer: My own professional opinion, not that of any of our healthcare clients or their PE funds) #AI #healthcare #enterpriseAI
Explore top content on LinkedIn
Find curated posts and insights for relevant topics all in one place.
View top contentOthers named Ben Magnano
2 others named Ben Magnano are on LinkedIn
See others named Ben Magnano